|
- 积分
- 3
- 威望
- 3
- 包包
- 15
|
A review of gene and stem cell therapy in cutaneous wound healing
' t; O0 }0 W+ Q- m/ TA Stem Cell Niche for Intermediate Progenitor Cells of the Embryonic Cortex
, ]' Z* w( Z: L" bAcute Complications of Stem Cell Transplant
. _. A5 Q% U% ?7 ^" y& z2 uAdhesion within the stem cell niches
0 L) F3 c7 N9 l% s8 c- qAllogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma / \3 n) F% G* ~- T1 @9 r" o
Beliefs About Science and News Frames in Audience Evaluations of Embryonic and Adult Stem Cell Research
. n: l8 O' g! m. Gbone-What is the true nature of the osteoblastic hematopoietic stem cell niche
1 |. y8 m% c6 K0 h; hApoptosis signaling in cancer stem cells
2 ~" P2 E# V8 W$ P" E0 lNonmyeloablative and Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
2 B/ p) b" v1 L5 W) ~) S% jRecurrence cancer stem cells
1 j' f! k1 _, P- Q1 kStem cells in melanoma development
. Y& @9 H) ]2 [# P2 F4 [Competitive Interactions Between Cells * b# t2 R8 H8 W
Cord blood stem cells for hematopoietic stem cell transplantation in the UK
! n5 y$ W8 _- P c% y( V8 N, MA chronic 1 year assessment of MRI contrast agent-labelled neural stem cell transplants in stroke $ q( @; [: f; N' [3 _9 `
Cardiac stem-progenitor cells, secreted proteins, and proteomics
# h- [( l7 z" T9 j* W7 yCardiovascular stem cells in regenerative medicine
; `6 ?5 B! \. D% g; h1 {Endogenous stem cells in patients undergoing coronary artery bypass
6 N5 j6 M0 v" z4 R0 Q% k2 PEnhancing cardiac stem cell differentiation into cardiomyocytes 1 L7 F7 R0 r' c4 E; B
In Vivo Imaging of Stem Cells and Beta Cells Using Direct Cell Labeling and Reporter Gene Methods |7 S) G# @. D' J- V) B1 C. _% N0 y9 D& W
Resident cardiac stem-progenitor cells for cardiac regeneration
9 ?& _* M4 _, a* Q+ q# @3 `S1+ Stem Cell Survival and Engraftment in the Infarcted Heart
0 S- f8 j5 |* I4 B% YStem cell engineering for treatment of heart diseases - k) M7 i1 Y4 ]; d( C2 O1 z+ v7 J
Stem cell therapy in acute myocardial infarction
! o" D* i2 J6 e) u0 UStem Cell Therapy Is Proarrhythmic " m2 ?8 X" y4 K6 E9 [4 G" k9 G
Stem Cell Therapy-A Primer for Interventionalists and Imagers
! g; Y+ d; x; I4 z" R, N5 a( Qdiabetes-Mesenchymal stem cells-Stem cell therapy perspectives for type 1 diabetes
9 M3 v0 {0 s/ T1 TEmbryonic stem cells as a model for cardiac development and disease
5 j$ N0 W& Z+ I% b6 G9 Q% z) FEpigenetic dynamics of stem cells and cell lineage commitment
- S$ L5 G9 q1 c b# X/ @) Y7 c5 KEpileptic Spasms After Stem Cell Transplantation for Chronic Epstein-Barr Virus Infection
! J) T3 @2 t# tExpanding Indications for Stem Cell Transplantation
5 R" \8 Q" U. t" d( K) Z5 ~6 C9 PFatal nephrotic syndrome complicating allogeneic stem cell transplantation + h6 d: s, {$ S3 Z* k% B) S# ^, X
Growth Factors, Matrices, and Forces Combine and Control Stem Cells $ g3 z1 B" D' c C) [$ v
Hematopoietic stem cell origin of adipocytes
" V) V# h9 i' s1 |; p$ ?+ l& {: n% GHepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis 3 k2 x+ D) V! e9 ?4 x& s
Long-term microcarrier suspension cultures of human embryonic stem cells * h6 w* V: L; H) C3 T' _" n
Microsphere-based tracing and molecular delivery in embryonic stem cells 2 i& b# [% z" N0 \! j3 t) U6 |5 b
Microspheres as a vehicle for biomolecule delivery to neural stem cells + Y" `9 x* V1 [* R
New insights into liver stem cells
6 A+ q8 U# v" l( i' I4 \A NEUROSURGEON'S GUIDE TO STEM CELLS, CANCER STEM CELLS, AND BRAIN TUMOR STEM CELLS
9 K- u/ D5 k+ r) ~. ?Regeneration of the ischemic brain by engineered stem cells
8 i; ~9 V2 B3 q0 B( q5 @; YStem cell-based cell replacement strategies for the central nervous system
( l& O2 G( M+ _Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction ' s2 w6 v$ M/ n5 H
Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction
. j0 E6 F6 W9 \, P+ \" q" `/ }Pluripotent stem cells as new drugs
/ t& X- B- B5 E0 a& Y+ Xregenerative-The complexity of cellular dedifferentiation-implications for regenerative medicine
$ g; a* _. T- o% X Q6 o, Nrespir-Cell therapy approaches for lung diseases
& h) F' y- a) F3 U* b% n5 LRisk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
0 @" w: v4 r1 O) m) rRole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation 0 [% n* P9 X" g0 Q) Q
Role of Hematopoietic Stem Cell Transplant in the Management of Follicular Lymphoma
# l! _" d0 l) w1 h$ [- t! \: Q0 e2 oStatus of adult marrow stem cell biology . B$ Z% C, \+ k' R
Stem cell and genetic therapies for the fetus $ o& f. x( ~ n: J- o5 u. Y
Stem cell decision making and critical-like exploratory networks
5 g8 o) [+ k3 f# ~Stem Cell Therapy for Heart Failure , s" ^7 w8 |9 T0 P/ a) H
Stem Cell Therapy for the Kidney
& Y( q( w: s9 [. r' x- hStem Cells and Liver Regeneration 0 Q4 k# p. k+ s/ V6 C
Stem cells, microenvironment mechanics, and growth factor activation
4 |+ g1 W8 ?# `* G/ QStem cells-The highs and lows of pluripotency i6 t4 r- K' K) p7 N4 ^& Q& r: v ?
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation
' W. `4 k( K8 ]. z: L& RSurvivorship Issues in Hematopoietic Stem Cell Transplantation $ k$ J5 v7 J9 L6 `# }
Telomere length maintenance in stem cell populations ) y$ Q U: l N& B1 T# X4 g1 \
Teratoma formation by human embryonic stem cells * r" y7 D- m h9 V
The Development of Inflammatory Arthritis and Other Rheumatic Diseases Following Stem Cell Transplantation ! T' ^" _7 K2 q! ^& U
The Increasing Complexity of the Cancer Stem Cell Paradigm ' o" v8 I% E0 a
The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis 1 C1 |5 g. x E5 s# R
Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation
* l! @! M$ r1 l# T& N+ eVariation in the safety of induced pluripotent stem cell lines
8 Z3 \8 E7 f1 b% j, G CA niche play for stem cells
/ u) o7 f4 Y+ p+ `A niche play for stem cells
3 e1 l2 \ w! I5 RA parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells
+ `- f6 S ^. ?6 B# M* M9 v- lAcute Complications of Stem Cell Transplant . P4 K0 h+ {! \, g% F
Adipose-Derived Stem Cells
0 y/ s: J# _& B. [0 i- f% r; ?Adult neural stem cells in the mammalian central nervous system
* W5 D! Z" j3 w& s; {' _* mApoptosis Signaling in Cancer Stem Cells
7 U- H1 e W oAutomated selection and collection of pluripotent stem cell colonies using the CellCelector 3 F- \& a. [' T+ V4 }- l' x
BCOR regulates mesenchymal stem cell function by epigenetic mechanisms
( y$ K7 ]: G `9 s1 n8 {' |! PBmi-1, stem cells and cancer
' A# n$ J# c# g3 x& @ v% ^# j. scancer stem cell marker
/ `6 D9 _: V7 b7 NCancer stem cells
* h9 d6 I( L) K" ^9 T4 X3 XClinical Applications of Blood-Derived and Marrow-Derived Stem Cells for Nonmalignant Diseases
) B+ G0 N% {0 l6 Z. F, L5 o; ^5 jCompetitive Interactions Between Cells-Death, Growth, and Geography 3 j! [+ H; W+ D! ~( v' P0 L
Potential novel pharmacological therapies for myocardial remodelling ( s! V& }: h: Q |" d c; T O# k
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
( f. D/ e; N1 c) cElite and stochastic models for induced pluripotent stem cell generation 1 s7 Y0 y: D& g3 M, J% I2 R
Embryonic stem (ES) cell-derived cardiomyocytes % `6 Q, p9 B) h+ j! X0 ?9 o0 } m
Emerging Immunology of Stem Cell Transplantation
% e; J0 A; l+ |9 h! G. WEthical Issues in Stem Cell Research
3 O, I* `; m# t' ~FDA Regulation of Stem Cell Based Products * `) ]6 X2 w7 G. R$ P0 U
Growth Factors, Matrices, and Forces Combine and Control Stem Cells 0 x( n |" z! C9 F* D- f1 F
Human embryonic stem cells and cardiac repair . \% l Q: ]+ r. i! Z9 D5 ]6 C1 n
Human Fetal Membranes-A Source of Stem Cells for Tissue Regeneration and Repair
4 s* `1 ?% }0 [: _* K" Q; J7 A7 v7 LHuman ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages / h* R9 |* ?$ |& [# |4 j0 ?
IFN-wakes up sleeping hematopoietic stem cells
$ \$ M3 l6 U( N5 D& c: XImaging Stem Cell Implant for Cellular-Based Therapies
1 g; G' f3 s6 @! @: @3 qImplications of the Cancer Stem-Cell Hypothesis for Breast Cancer Prevention and Therapy
: m3 k8 y6 d$ _ d8 |9 q. f+ y! SInduced pluripotent stem cells and the stability of the differentiated state 1 U9 I; [# B4 p% Z
Instructing an Embryonic Stem Cell-Derived Oocyte Fate ( k/ n, U/ _; a! Z
Medical Innovation Versus Stem Cell Tourism * n0 m g) m5 }$ i) ~# A" w
In Search of Adrenocortical Stem and Progenitor Cells
- v8 g2 r* h; `! v1 Q0 b$ \Neural stem cells aplenty
$ S4 U( m# k, `Pancreatic cancer stem cells
2 a- ^! S D7 sParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
/ V- b& T8 K! g9 {, E& S8 v3 I$ lPsychological Issues of Stem Cell Transplant * ^+ y: j a+ m* ]9 s" `, B
Regeneration of the ischemic brain by engineered stem cells 5 @0 F6 y% T1 w" X5 n. Y
Regulatory circuits underlying pluripotency and reprogramming
, e' d) S9 z: c* E D+ Qrespir-Cell therapy approaches for lung diseases
: w4 Y; w+ e F5 d5 pRole of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation 3 C2 t# I0 f, V* n& p
specific microRNAs promote induced pluripotency 6 O! b. ~- X, \1 B
Stem Cell Therapy for the Kidney i+ R6 { g# x" c8 l5 k
stem cell therapy in cutaneous wound healing
9 g" a5 I' k, PStem cell therapy perspectives for type 1 diabetes 5 D* U' \% m& U
Stem Cells and Liver Regeneration
( _8 J) ~7 n6 C0 @& c3 UStem cells based transplantation for cardiovascular diseases in China : l- f2 }( Z, ^$ E/ J
Stem-cell therapy faces more scrutiny in China
2 r7 k7 t# k d0 z; j2 a# p- p& @Steps to the Clinic
! E, Z2 n: @9 m# J7 uStepwise differentiation of pluripotent stem cells into retinal cells
% [, b2 `' {6 p! B! x7 n1 @Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche 9 u; x7 l. W: Y5 d: G8 w6 V
The Increasing Complexity of the Cancer Stem Cell Paradigm
' W. @/ I/ q. D+ H+ xThe NIH Draft Guidelines on Human Stem Cell Research
7 W9 G% \0 W0 ]% tThe pluripotency factor Oct4 interacts with Ctcf and also controls X-chromosome pairing and counting
" Q% M) b! Y, q pThe Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair
' U8 \$ h1 [8 k* m/ C1 nThe tumor stem cell concept 7 R* m1 H' \- a8 o0 F" N$ T
Umbilical cord blood stem cells-Towards a proteomic approach
; S# y7 R3 ]5 V0 j8 {# z+ jUS regulator wades into stem cell therapies for heart disease 5 L4 o1 J8 _; Y4 }% K ~
Apoptosis Signaling in Cancer Stem Cells 8 N2 C4 V7 W/ k& y
Pancreatic cancer stem cells : q0 f) r) I( a* Z9 F
Acute Complications of Stem Cell Transplant
0 p6 J/ _0 \, i5 MAutologous Stem-Cell Transplantation in Patients With HIV-Related Lymphoma 9 _/ Z+ U" s8 I
Deconstructing Stem Cell Tumorigenicity-A Roadmap to Safe Regenerative Medicine + H. `/ M0 _1 o. a
Emerging Immunology of Stem Cell Transplantation
$ Z y( R1 A# d0 z+ p. yManagement Issues In Hematopoietic Stem Cell Transplantation * ^. O0 k% `5 |; U8 I- [4 p
Psychological Issues of Stem Cell Transplant 2 l2 Y" E' h8 L5 g
The NIH Draft Guidelines on Human Stem Cell Research
' d/ U6 x5 |( j* l2 j, @The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis
. r0 M* w2 H1 a9 ~8 T+ o7 t4 }5 j" e0 sBone Marrow-derived Stem-Progenitor Cells-Their Use in Clinical Studies for the Treatment of Myocardial Infarction f6 R7 u9 k1 }
Embryonic stem (ES) cell-derived cardiomyocytes
8 O+ Z) u- J8 g2 u5 t0 \Embryonic stem cells as a model for cardiac development and disease - n' [2 j2 D9 `1 G
Endogenous stem cells in patients undergoing coronary artery bypass graft surgery
, M3 K' m$ M6 C5 JHuman embryonic stem cells and cardiac repair 2 k& h+ `8 ?* |# K" W
Percutaneous intramyocardial stem cell injection in patients with acute myocardial infarction $ f# y9 t( G. R: \9 l* V* J) u, ]/ b9 s
Promise of Blood-and Bone Marrow-Derived Stem Cell Transplantation for Functional Cardiac Repair
# Y$ i4 v0 J& s m- C" ^% rStem Cell Therapy for Heart Failure
! h' C( e. {( w5 g5 REpithelial metaplasia-adult stem cell reprogramming and (pre)neoplastic transformation mediated by inflammation {0 k; R8 U. y1 |+ S) g
Full text access provided to Peking university 5 V9 Q2 P) }. U, U3 V N* H9 {7 ~, ]
Improving stem cell mobilization strategies-future directions
, I6 x2 p% B3 y) H% q, JInduced pluripotent stem cells from a spinal muscular atrophy patient ; X. ]6 s A0 q8 r! {6 C, ?4 M
Induced pluripotent stem cells-current progress and potential for regenerative medicine . O% g; U) U/ j7 [4 \
Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon鈥揹ependent exhaustion
: D+ {1 D5 ]0 h* N) ULow-risk reprogramming 4 N! s& s' C+ P) g- t
Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells 7 r7 z/ U4 m+ G w
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells 1 { V" D P1 d$ q5 d; U# u
Pluripotent stem cells as new drugs " \5 g/ w* `4 V
proteome-Umbilical cord blood stem cells-Towards a proteomic approach : i! _, o% C1 B6 A0 E6 p
Regeneration of the ischemic brain by engineered stem cells 5 i3 n" s k% ~& T& F
Researchers Generally Happy With Final Stem Cell Rules
* O& T! R3 z, M+ V( pStem Cell Niche
, S1 D8 B9 M s( q5 ~' OStem cell therapy perspectives for type 1 diabetes
; N% X [- Q" i7 @. p2 _Stem Cells and Liver Regeneration
3 v" ^5 b1 G V# {$ E1 WStem cells-Fast and furious
5 i4 x {4 ^" b4 [+ U, bSurvivorship Issues in Hematopoietic Stem Cell Transplantation
+ O6 Q& y' P' UThe NIH Draft Guidelines on Human Stem Cell Research ! j& Y* c6 Z) r% I5 j: h* q
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases 6 X- [. C" N f3 _$ N4 r
US stem-cell research expands
8 |* r M; ]2 u1 @% x' WVirus-free induction of pluripotency and subsequent excision of reprogramming factors
" N& E7 H5 R- z7 A4 cWnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin |
|
发表于 2009-10-29 19:08
